Abstract:Inappropriate expression of the receptor tyrosine kinase Met and its ligand hepatocyte growth factor (HGF)/scatter factor (SF) is usually associated with an aggressive solid tumor phenotype (angiogenesis, invasiveness, and metastasis) and poor clinical prognosis. We report here the design and construction of a large, human naïve antigen-binding fragment (Fab) phage-display library with a diversity of 2.0×109, which allows rapid isolation of antigen-specific human antibody fragments. A Fab fragment specifically against Met (designated hFab-Met-1) was successively selected from this library by using biopanning on Met-transfected cell line S114. The specificity of hFab-Met-1 was characterized by immunoprecipitation, Western blotting, and flow cytometry. The results demonstrate that hFab-Met-1 reacts with the extracellular domain of Met in its native conformation. Moreover, functional analysis by Madine-Darby canine kidney cell scattering and urokinase-type plasminogen activator assays demonstrated that hFab-Met-1 is not an agonist to HGF/Met signaling compared with a murine intact monoclonal antibody (MAb) Met5. To confirm that hFab-Met-1 interacts with Met-expressing tumors in vivo, I-125-labeled hFab-Met-1 was nuclear-imaged in a mouse xenograft of Met- and HGF/SF-expressing human leiomyosarcoma. Total body scintigrams were obtained between 1 and 48 h postinjection (PI). Tumor-associated activity was imaged as early as 1 h PI, and remained visible in some animals as late as 24 h PI. As expected, activity was highest in the kidneys in early images, whereas thyroid activity became predominant in later images. In conclusion, hFab-Met-1 interacts with Met both in vitro and in vivo, and is a promising candidate for clinical diagnosis and therapeutics.

Selection and Characterization of Human Anti-MAGE-A1 Scfv and Immunotoxin

THE RECOMBINANT ANTI-MAGE-A1 IMMUNOTOXIN INHIBITED THE GROWTH OF HEPTACELLULAR CARCINOMA CELL BEL7402

[A Specific Human Scfv Against Malignant Melanoma Selected from a Large Human Phage Antibody Library].

Cloning, Prokaryotic Expression, and Antibody Preparation of Human MAGE-1

Selection and Characterization of Human Scfv Antibodies Against Hepatocellular Carcinoma

Selection and characterization of a human neutralizing antibody to human fibroblast growth factor-2.

Cloning and expression of human melanoma antigen MAGE-A10

Construction, Expression and Functional Analysis of Anti-B7-h4-scfv-ch3 Recombinant Antibody

Expression,purification and Preliminary Identification of a Novel Immunotoxin Against Hepatocarcinoma

Identification of Two Novel Hla-A*0201-Restricted Ctl Epitopes Derived from Mage-A4

Affinity Maturation and Characterization of Internalized Human Anti-Met Recombinant Antibody Fab

Preclinical evaluation of a novel CAR-T therapy utilizing a scFv antibody highly specific to MAGE-A4p230-239/HLA-A∗02:01 complex

Screening and characterization of human anti-GPC3 single chain Fv antibody fragment selected by phage display

Prediction, Synthesis and Identification of HLA-A2-restricted Cytotoxic T Lymphocyte Epitopes of the Tumor Antigen MAGE-n

Construction and characterization of an anti-asialoglycoprotein receptor single-chain variable-fragment-targeted melittin.

Selection of anti-cancer-associated gene single-chain variable fragments derived from gastric cancer patients using ribosome display.

Expression, Purification and Characterisation of a Human Anti-Cdk4 Single-Chain Variable Fragment Antibody.

Construction of Human Naïve Fab Library and Characterization of Anti-Met Fab Fragment Generated from the Library

The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model.

Construction of human phage display scFv library against mastocarcinoma

[Production of phage-displayed single chain variable fragments of monoclonal antibody MGb1].